An announcement from BeiGene Ltd ( (HK:6160) ) is now available.
BeiGene Ltd announced the grant of 38,919 Restricted Share Units (RSUs) to 184 employees under its 2016 Share Option and Incentive Plan. This move, which represents approximately 0.04% of the company’s total issued shares, is part of BeiGene’s strategy to align employee incentives with company goals, although the grants are not tied to performance targets or clawback mechanisms.
More about BeiGene Ltd
BeiGene Ltd is a biotechnology company focused on the development and commercialization of innovative molecularly targeted and immuno-oncology drug candidates for the treatment of cancer. The company operates with a global market focus, aiming to address unmet medical needs in oncology.
YTD Price Performance: 15.11%
Average Trading Volume: 4,210,559
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$240.1B
See more data about 6160 stock on TipRanks’ Stock Analysis page.